Primary Care Clinics in Hampton, VA Accepting Medicare
48 Primary Care Clinics found. Showing 41 - 48
 Hampton Roads Gastroenterology, P.c. Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 501 Medical Dr, Hampton, VA 23666 Phone: 757-826-3434 Fax: 757-826-9028 |
Center For Medication Therapy Management & Outcomes Research Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 19 Indian Rd, Pharmacy Annex, Hampton, VA 23669 Phone: 757-727-5000 Fax: 757-727-5840 |
Old Hampton Family Medical Associates, P.c. Family Medicine Medicare: Medicare Enrolled Practice Location: 26 Wine St, Hampton, VA 23669 Phone: 757-728-1100 Fax: 757-728-0870 |
Serenity Mental Health And Wellness Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 4410 Claiborne Sq E Ste 343, Hampton, VA 23666 Phone: 716-548-8644 |
Francis Family Practice Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2106 Executive Dr, Hampton, VA 23666 Phone: 757-827-9979 |
Tidewater Family Health Centers, Ltd. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2019 Cunningham Dr, Suite 202, Hampton, VA 23666 Phone: 757-827-0767 Fax: 757-838-4918 |
Sentara Family Medicine Physicians Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2104 Executive Dr, Hampton, VA 23666 Phone: 757-736-3700 Fax: 757-827-9978 |
Rmcc-mercury West Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3401 W Mercury Blvd, Hampton, VA 23666 Phone: 757-827-1940 Fax: 757-896-4716 |
News Archive
Probiotics do not help prevent gastrointestinal colonization with MDROs in critically ill patients
Probiotics show no benefit for preventing or eliminating gastrointestinal colonization with drug-resistant organisms in patients in the intensive care unit compared to standard care, according to new research published online today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
Experimental drug nivolumab shrinks tumors in patients with advanced melanoma
An experimental drug aimed at restoring the immune system's ability to spot and attack cancer halted cancer progression or shrank tumors in patients with advanced melanoma, according to a multisite, early-phase clinical trial at Johns Hopkins Kimmel Cancer Center and 11 other institutions. All patients had experienced disease progression despite prior systemic therapies, and most had received two or more prior treatments.
Mitofusin 2 protein could serve as therapeutic target to ameliorate sarcopenia in older adults
One of the alterations that most affects the quality of life of the elderly is muscle wastage and the resulting loss of strength, a condition known as sarcopenia. At about 55 years old, people begin to lose muscle mass, this loss continues into old age, at which point it becomes critical.
Specific immune system genes may determine how long people can live with glioblastoma
Researchers have identified a group of immune system genes that may play a role in how long people can live after developing a common type of brain cancer called glioblastoma multiforme, a tumor of the glial cells in the brain.
› Verified 3 days ago